Medical Journals

Regeneration of Nigrostriatal Dopaminergic Axons by Degradation of Chondroitin Sulfate is Accompanied by Elimination of the Fibrotic Scar and Glia Limitans in the Lesion Site.

Authors:
  • Li Hong-Peng
  • Homma Akiko
  • Sango Kazunori
  • Kawamura Koki
  • Raisman Geoffrey
  • Kawano Hitoshi

From: Department of Developmental Morphology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo, Japan.

Journal of neuroscience research

  • Publish Date: Feb 2007
  • ISSN: 0360-4012
  • Volume: 85
  • Issue: 3
  • Pages: 536-47
  • Medium: Print
  • Language: English
  • Citation (JAMA): Li Hong-Peng, Homma Akiko, Sango Kazunori, et al. Regeneration of Nigrostriatal Dopaminergic Axons by Degradation of Chondroitin Sulfate is Accompanied by Elimination of the Fibrotic Scar and Glia Limitans in the Lesion Site.. J. Neurosci. Res. Feb 2007;85:536-47

Abstract

Chondroitin sulfate increases around a lesion site after central nervous system injury and is believed to be an impediment to axonal regeneration, because administration of chondroitinase ABC, a chondroitin sulfate-degrading enzyme, promotes axonal regeneration of central neurons. To examine the physiological role of chondroitin sulfate up-regulation after injury, the nigrostriatal dopaminergic axons were unilaterally transected in mice, and chondroitinase ABC was then injected into the lesion site. In mice transected only, tyrosine hydroxylase-immunoreactive axons did not extend across the lesion at 1 or 2 weeks after the transection. Immunoreactivities of chondroitin sulfate side chains and core protein of NG2 proteoglycan increased in and around the lesion site, and a fibrotic scar containing type IV collagen deposits developed in the lesion center. In contrast, in mice transected and treated with chondroitinase ABC, numerous tyrosine hydroxylase-immunoreactive axons were regenerated across the lesion at 1 and 2 weeks after the transection. In these animals, chondroitin sulfate immunoreactivity remarkably decreased, and immunoreactivity of 2B6 antibody, which recognizes the stub of degraded chondroitin sulfate side chains, was enhanced. Furthermore, the formation of a fibrotic scar and a glia limitans that surrounds the former was completely prevented, although type IV collagen immunoreactivity remained in newly formed blood capillaries around the lesion site. We discuss the question of whether the chondroitin sulfate is acting as a direct inhibitor of axonal regeneration or whether the observed changes are due to a prevention of the fibrotic scar formation and a rearrangement of astrocytic membranes.

Mesh Headings (Keywords): Animals, Axons, Brain Injuries, Chondroitin ABC Lyase, Chondroitin Sulfates, Cicatrix, Corpus Striatum, Dopamine, Male, Mice, Mice, Inbred ICR, Models, Animal, Nerve Regeneration, Neuroglia, Substantia Nigra


Check for Full Text / PubMed Unique Identifier (PMID): 17154415


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.